US drug companies seek removal of judge set to preside over opioids trial
of the judge set to preside over a landmark trial in which it will be claimed deceptive marketing and a lack of oversight helped fuel the opioid addiction crisis. A 39-page petition filed in the early hours of Saturday claimed that US district judge Dan Polster’s “unusual level of commitment” to reaching a settlement in the case had affected his decision-making, leading him to turn “a blind eye to the law”. The request comes after a series of rulings against the drug industry ahead of the trial scheduled to begin in Cleveland, Ohio on 21 ...
Click
To Read Full Article